Poland· PL-100301856

Cyclo 3 Fort

A medicinal product containing produkt złożony, registered in Poland by InPharm Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCyclo 3 FortATC—REGISTER NO.PL-100301856PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909997224954
  • gtin
    05909997224961
  • gtin
    05909991204174
  • gtin
    05909991204181

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a96bb68e-858a-46e0-80a7-9cf46f2813c1
GET /v1/drugs/a96bb68e-858a-46e0-80a7-9cf46f2813c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "150 mg + 150 mg + 100 mg",
  "packaging": "05909997224954 ¦ OTC ¦ 85781\n30 kaps.\n05909997224961 ¦ OTC ¦ 85782\n60 kaps.\n05909991204174 ¦ OTC ¦ 106108\n20 kaps.\n05909991204181 ¦ OTC ¦ 106109\n40 kaps.",
  "substance": null,
  "common_name": "Produkt złożony",
  "pl_product_id": "100301856",
  "pozwolenie_nr": "336/13",
  "auth_procedure": "IR",
  "authorisation_validity": "2028-07-19"
}

See everything about produkt złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.